Bobbie: Laura Modi. How a Baby Formula Startup Took Market Share From Two Industry Giants
from How I Built This with Guy Raz ·
79m 48s
Laura, a mother and former employee at Google and Airbnb, founded Bobby after realizing the U.S. infant formula market was stagnant, unregulated, and failing to meet modern nutritional standards. Inspired by European practices—such as higher DHA and balanced iron levels—she created a safer, more natural formula for babies. Initially, the venture faced skepticism, regulatory challenges, and a major setback when the FDA intervened, accusing the product of misrepresentation. Despite this, Laura’s team remained resilient, building a community of parents and a deep understanding of maternal challenges. A key turning point was when a major manufacturer, Perago, expressed interest after observing how Bobby handled the crisis with transparency and integrity. After 18 months of rigorous reform and supply chain retooling, Bobby secured FDA approval. The journey underscored the power of personal experience, empathy, and persistence in disrupting a deeply entrenched industry. The product was positioned as a companion to breast milk, not a replacement, allowing it to enter the market legally and ethically. Ultimately, Bobby’s success was not just in product innovation, but in creating a compassionate, inclusive narrative that resonated with parents who felt shame or exclusion in traditional parenting advice. The story highlights how small, human-centered ventures can challenge established systems when driven by genuine need and unwavering conviction.
When I pull up to a gas pump to fill my car,
I'm not thinking about chemistry or engineering.
I'm thinking about getting in, filling up,
and getting on with my day.
And it reminds me a little bit of the founders
I talked to on this show,
because the best ones obsess over things
their customers will never see.
Tiny details, invisible improvements, relentless iteration.
And not because anyone's watching,
but because it makes the product better.
That's what the mobile brand does.
It engineers fuel the same way
great founders engineer their products.
Mobile Supreme Plus Premium Gas
helps keep engines three times cleaner,
which can mean better performance
and improved gas mileage.
It's for people who care about what's under the hood,
even if they never see it.
Three times cleaner compared to mobile regular gas
in port fuel injected engines.
Actual results may vary.
Visit mobilefuels.com for details.
Success is a job.
Journey, especially when it comes to your finances.
One of the most common obstacles in our financial journey
is dealing with high-interest debt.
It can often leave people feeling trapped,
but it doesn't have to.
If you're dealing with high-interest debt,
there is a way forward.
A SoFi personal loan could consolidate
all your high-interest debt
into one low-interest monthly payment,
helping you craft a roadmap to paying down your debt.
It even comes with no fees
for your personal debt.
So, you know, by the way, this is something that, because humans are just so wired to see somebody in a uniform and assume something.
And you can literally get, you could go to your dad's company and buy a high visibility jacket and just start directing traffic.
And people would just assume, like anybody could do that.
I've always wondered about that.
That is so true.
You know?
You're totally right.
You could walk into a store and buy a high visibility jacket and do exactly that.
So, when you kind of went off to college, to university in Dublin, did you think,
you know, I'm getting out of this small town and it was great, but I'm going to start my life maybe in Dublin or London or somewhere else?
So, I'd gone to, my secondary school was in boarding school up outside of Dublin.
So, I'd already spent a few years outside of Westport and going back and forth.
But being in Dublin for college was some of the most formative years.
And it was also during the tech boom, of which most of that tech boom was happening in Dublin.
And I sort of watched.
I watched the renaissance of Ireland and Dublin happening at the time when the tech companies of the world were setting up.
Intel and Google.
That's right.
Yeah.
Exactly.
So, it was a great time to be studying there and to also watch how a city transformed to support really what was the next wave of industry.
Yeah.
And I guess you were really drawn to tech because I read that a few years after you graduated from college,
you had this ambitious goal that you set for yourself.
You decided that you wanted to work at Google in the U.S.
Yeah.
I think, Guy, it was such a dream.
You know, the idea that I would get on a flight and I would go live in California.
So, yeah, I applied for a job at Google.
I got the job and I'll never forget turning to my parents.
We were joking about what we wanted to do that Christmas that was coming up.
And I looked at them and I said, well, why don't you come visit me and the whole family come visit me out in California?
Yeah.
Yeah.
It was such a moment of pride and shock and excitement and my siblings as well.
I mean, it was such a beautiful moment.
So, yeah, I packed my bags and I headed out to California.
I'd never been.
And it was the dream that I was totally imagining.
Everything felt like a movie.
Everything.
And it wasn't just the space.
It was the mindset.
You know, I always joke, you know, back home in Ireland, you could tell someone like,
"Oh, you know, I want to be an astronaut."
And they would say, "Ah, would you get away
you're not going to space. Like they'll keep you grounded and they'll keep you grounded pretty
quickly. You tell someone over in San Francisco, over on the West Coast, they'll say, I have a
friend. I have a book. Let me give you the book. I can get you there. There was this beautiful,
open mindset to anything being possible. And when you go from the West of Ireland and find yourself
in the epicenter of it all, which is Google, wow, do you feel it?
And tell me about Google. What did you, you know, this was sort of the heyday of like
people riding scooters around Google and lunches and snacks everywhere. I think it still has some
of that. Tell me about your impression of the place.
It solved everything I wanted in my early 20s. I got my laundry done. I was fed. I was maybe fed
too much. I was given a level of,
work autonomy and freedom. But also I got to watch and it was, it was like doing an early MBA.
Not only are you learning from brilliant people, but the work ethic was just next level.
My day-to-day job was supporting product operations for Google Finance, which almost
felt like a little startup within itself. The goal at the time was to go up against Yahoo Finance,
which was the number one platform. And I had no real understanding of the stock market in,
in using, you know, these financial platforms before this, but I became such a fast learner.
I found myself day trading. So not only did I love working there and love the job,
I also felt like I was growing in my own sort of knowledge and understanding of a new world.
And how'd you do, by the way, as a day trader?
Not too bad. Actually, my first home was mainly the proceeds of some day trading.
Yeah. All right. So you were, you end up, you're at Google for about five,
five years, I think.
Yep. Just under five years.
And you join a small-ish, at that time, startup, Airbnb. It had started in 2008,
but still in 2011, it was gaining traction for sure. No question about it. But you got a job.
But tell me about that decision. I mean, it must have been
exciting to be part of something that you felt had a lot of potential.
So I remember I had to do a work trip to New York while I was working at Google.
And I had a colleague turn to me and said, well, why don't you just book an airbed and breakfast?
I was like, what the hell is this? So I go on the site and I book myself a two-bedroom flat.
And I remember calling my friends back in Dublin and Ireland. I was like, guys,
I have my own apartment in New York City. And I lived a real New York life. And I left that week
going, I have to work for this company. And I will do whatever it takes because whatever they're
doing, whatever they're on is game changing. There was an ounce of it that sort of felt a
little bit Irish, honestly. It had that real community feel. And you just, you could feel
the disruption. And when I said I would take on any job, I mean, that's what I did. I joined
to lead parts of operational roles. And I was sort of baton passed through the business in
multiple ways. But I knew I had to work there. Was there any part of you, and especially given
that you'd come from an entrepreneurial family, was there any part of you that was always thinking,
one day I'm going to start my own thing? Or was that not that important to you?
Always. I had a folder. My parents love to remind me of this. Just even growing up,
I would brainstorm ideas all the time. I would make up businesses. And, you know,
you're always looking for that spark. But I wasn't rushed. I think I got some great advice early on
too, which was, and especially knowing I was at Airbnb and Google, I had the most beautiful
opportunity to learn. Right. Okay. So you are at Airbnb and,
it's growing. And you also, at a certain point, become a new mom, which is going to,
it's transformational for most people who become new parents. It was for me,
and I'm sure it was for you. But it really became even more than that. So tell me a little bit about
becoming a parent. This is around, I guess, around 2016.
2016. So before my kid was my husband, who I actually met at work.
Before you had kids, your kid was your husband?
No, no, no, no.
Before kids, I met my husband. I met my boyfriend. We met at Airbnb. So we were
probably the first, you know, team couple to come from Airbnb and have our first kid as a couple
there. I, wow, guy, I mean, I went into motherhood just maybe with a certain belief of how everything
would work out. I watched my, you know, I had a grandmother who had 13 children. She also built her
own empire while doing it. I, I had a lot of examples around to say that you could become
a mother and you could do it all. And no one ever talked about all of the things that could go wrong.
But I went into motherhood and I immediately felt the tension between the highest of highs
and the lowest of lows, questioning everything.
Yeah.
You know, I say this all the time, but I,
I believe women can do anything, but maybe not do everything. But all to say,
I also found myself in a position questioning society and questioning the policies in the
world around me. I come from Europe where parental leave was way longer than what we
were offering here in the U.S. And I was watching the same government tell women that you should
breastfeed for six months, but we're not going to give you the paid leave to stay home and do so.
Let me just,
let me just clarify that. I mean, that was the message. I, you know, remember that. But where
were you, where do you remember hearing that? Like the pediatric, you know, American Pediatric Society?
Yeah, exactly. The American Academy of Pediatrics. That's a, it's a line that they use to advise
that this is the duration by which you should be feeding your child.
Right. Six months of breastfeeding because they say the data shows that it's healthier for a baby,
right? That there's outcomes with allergies and things like that. And,
um, tell me about how you handle that. Because that's a lot, especially because some mothers
can't produce enough milk for the baby. It's just, it's a very common thing.
My sort of founding story has been repeated multiple times. You know, I'm, I'm in a pharmacy
late at night recognizing that I'm unable to exclusively breastfeed her.
Yeah.
And mom, you are the only person responsible.
For doing that. This is something, it's the one job that you are expecting to do and that you
were naturally able to do. The skies would open up and it would be easy and beautiful and natural.
I mean, this is what the narrative is. And I found myself with an infection five days into
having her. It's a common infection of which if you get the right support, you can also navigate
through that. And I didn't, I didn't get the right lactation support. So it was,
I had a high fever at 11 PM at night and I'm walking through a pharmacy now looking for the
bell. I have to go ring the bell to get someone to come unlock it where they call over the,
you know, the microphone, like help on the formula aisle. And I'm going, oh my God,
the shame that I need to have someone come unlock the food to feed my baby that my body was meant
to be able to do naturally. I just felt like I, I had failed her. I had failed myself.
And I was disappointed. I was disappointed in it all. So I did the walk of shame. I'll never
forget buying that first can. And all I did was hoped that they put it into a bag that wasn't
see-through. That nobody would see you. Yeah. It's interesting because I think many people,
certainly men, would never think, well, what's shameful? Why would you feel shame? Like it's
not like buying cigarettes or, you know, or even like, you know, condoms or something, right? Like,
but actually, I mean, if the,
if the message is you should only breastfeed, then yeah, there's this feeling of like,
what's wrong with me? In society, we love a binary narrative. There's right, there's wrong,
there's this, there's that. And in that moment, what I realized is that we have failed all women
and mothers in recognizing that it's not binary. It is absolutely a journey. And there's a million
and one ways by which you can feed your baby. But for whatever reason, when I open up social,
when I read an article, when you pick up that first parent book, there is a message being put
back at you that breast is best. And that is the only way that you should feed your child.
And I get home and I think something about this doesn't feel right. Yeah. We can do better.
I think the intention behind that is good, right? It's like, hey, you know, this is a
natural, whatever our bodies have been producing this since, you know, and this is,
is proven over, you know, tens of thousands of years to be the best model.
A hundred, like, I want to make sure that is extraordinarily clear.
Breast milk is the most beautiful, dynamic, liquid gold for a reason. And it is magical.
And it has so many properties that can never be replicated. No formula could replicate the magic
that is breast milk. And yet, even with that being true, the other truism that we hold,
near and dear, is that not everyone can do it exclusively. And if they can't, that's okay.
fabulous alternatives, and you can thrive on something else.
All right. So you are a new mom, and you're experiencing this, and you are on leave at the
time. And does it start to spark a germ of an idea right away? Or are you, I mean, tell me what you
start to notice about baby formula? So as a crazy researcher, just in life,
everyone assumes like, oh, you had the problem, and then you went and you decided to start a
business. And it was nowhere near that at all. I mean, like, you know, I was 40 pounds overweight,
I was exhausted, I was a shell of a human. But I go home, and I pull out this can of formula.
And I did what every crazy researcher mom does. I went to Google, and I started going, what is
this ingredient? And what's the impact of feeding my baby this formula? And how do I make a bottle?
And how do I tell my husband? And how do I tell my mother?
And you're just one question, one question, one question, you're going, you're going deep.
And now it's two in the morning, you're under the sheets. Those questions ended up turning into
industry questions, like, why is it that two companies in the US own the market?
Why is it that the formula hasn't changed in 40 years? The questions evolved from
the basic mom questions to now the curiosity I had as a budding entrepreneur to go,
something is here, there is an opportunity to come in and do something better. And I spent the next
year going back to work, having Mary and what I would refer to as my mini PhD.
And just kind of, I mean, as a parent, right? Like, I remember when our first kid was born in 2009,
the BPA thing just started to get a lot more traction. And so, I mean, we used glass bottles,
we were using, you know, we were sort of freaks, like we used a cloth,
diapers. You're talking about 2016. By this point, it was natural for you as a parent to like
investigate every single thing you were putting in your baby's mouth.
Yeah. And look, also, I was a European mother, now having my first American baby.
So, I went straight down the rabbit hole of doing the US comparison to Europe very quickly.
And what did you find? Like, what was the difference between baby formula
in the US versus Europe at the time?
So, the biggest was that the European nutritional standards that were governed by the EC
were updating those standards every four to five years. And then I did the comparison to that over
here in the US, and I realized the last time that the US updated their nutritional standards
was in the 1980s. When I sort of took a step back in it, I think the biggest
wake-up call was that infant formula was just ignored here in the US.
It's interesting.
It's interesting because I, like, the European infant formulas were or not, and probably still
are not, approved to be sold in the US because, understandably, baby formula is super highly
regulated.
And it has to be. I mean, it is an essential food being fed to the most vulnerable audience. It
has to be highly regulated. And, you know, in the same way that I believe in not shaming how
one feeds, I also don't believe in the shaming of different formulas. There's going to be a level
of access and affordability and choice that you never want to look back on as a parent and go,
I should have, and I could have, and I would have. That is an unfair weight that no parent
should ever go through. And again, we can also all look at each other and go, but shouldn't
there be choice? And shouldn't we be evolving to be better?
All right. So this is 2016. And mainly, I think then and probably still now, the biggest brands
were Enfamil and Similac, which are made by Enfamil. And Enfamil is the biggest brand that's made by Enfamil.
Similac, which are made by Enfamil's Mead Johnson, Similac is Abbott, which is a huge pharmaceutical
company. And they have really kind of dominated the Coke and Pepsi of baby formula, right?
Yes. They are the Goliaths of this industry. And they have for decades.
And the standards were more or less unchanged for 40 years.
Correct.
Obviously, they had nutrition that the FDA had deemed, you know, was necessary and the minimal
standard. And they had nutrition that the FDA had deemed, you know, was necessary and the minimal
standards for infants, I guess, fats and certain vitamins.
Carbs, proteins.
What ingredients did you find that were different between what you saw in U.S. baby formulas and in
European ones?
DHA was the biggest.
And DHA, which is the nutrient that supports brain health.
Yep. DHA was not just mandatory in Europe, but there was a level that was higher than
any formula was choosing to do here in the U.S.
So, there's a lot of examples where the levels are different. Example, iron's a great example here,
where there's a belief, and I really think this is also an American belief,
that fortification and more is always better. That's not always the case.
Designing, especially something like the sole nutrition to be optimal for what the baby needs
is really critical because too much iron early on can have negative consequences much later in
life.
So, when you look at the iron range in Europe compared to the iron range here in the U.S.,
they're wildly different.
So, as you start to figure out what to do, did you get friends to bring you baby formula from
Europe to the U.S.? Or were you just buying, you know, whatever? Maybe you get Earth's Best or
maybe use Similac. I don't know. What were you doing?
I originally bought Similac. And then I realized that there was this thriving,
black market over in the U.S. where parents were buying European formula. And they were
packing suitcases full of European formula and shipping it into the country.
And selling it on Amazon or?
Selling it in the local car park. They were really hoarding it for themselves.
And that was another signal. It was like, okay, there's a black market bubbling here.
So, clearly, there's a desire to create better formula. And I just couldn't get off the idea
that we should be able to make European quality formula here in the U.S.
Okay. But you're still, I mean, as a parent researching this stuff,
and I guess a year later, 2017, you get pregnant, you're pregnant again with your second child.
It was on the eve of 2018, January 2018. Yep.
Okay. But what was the point where you were like, you know, I could do this. Maybe I should
do something here.
Well, I peed on the stick and I found
out I was pregnant for the second time. And that feeling of, okay, I'm not having this kid until
there's a better formula in the market. It was within days of peeing on that stick, I turned to
my husband and I said, I'm going to go do this full time.
You were going to, you decided to leave entirely. You're going to leave your job at Airbnb.
Exactly. And, you know, the conversation even with my husband at the time,
you're pregnant with your second kid. You're living in an expensive city.
You have a dream. You have strong belief in it. And you also need to have him believe in it because
I'm deciding to leave a salary aside and take parental leave to now go build a company and
have to also self-fund this and get it off the ground. And that meant picking up some part-time
work and doing some consulting here and there, coupled with turning to my bank account over in
Ireland, where I took all my communion money. And I was like, I'm going to do this full time.
Everything I had built over the years and start a little nest egg to get this going.
Yeah. Because, I mean, you presumably had shares from Airbnb, but it wasn't going to go public. It
didn't go public until 2020. So you didn't have any liquidity probably at that point.
Zero. No liquidity. I think I had also mapped out a business plan that matched my trimesters
at the time. I was like, okay, trimester one, here's what I'm going to nail. But I was depleting
capital, my funds, way faster than I had anticipated.
And meanwhile, you need to start doing more research on baby formula, right? So what did
you do? How did you go about that? Yeah. I'm not a scientist. And I
turned to Google and I typed in baby formula expert and I found a baby formula expert.
I ended up contracting her and we worked hand in hand every day together. She took my vision of
dream ingredients and recipe and she helped formulate it. And it was one sort of hire after
another, but the bills came in. You're cold calling so many people. Between, I don't know,
8 p.m. and 11 p.m. at night, I was on LinkedIn aggressively and I was pinging everyone and
anyone who had a name that could relate to formulating something I knew I needed to get
started. And I found me regulatory experts, scientists, doctors, and we spent those trimesters
taking it from idea to ultimately a formulation and concept.
Did you give yourself a budget? Like, did you say, okay, I've saved, you know, over my career now,
I've got $100,000 or whatever, and I'm going to use that and take a risk with that. And if it
And then it went up to around 80.
And then I ultimately ended up spending close to $200.
Wow.
And I pulled it from everywhere.
All right.
So I want to kind of get a sense of what you are facing.
I mean, because it's not that different today, right?
The biggest baby formulas are produced by these two giants, right?
And this is a huge, I think 75%, 80%, maybe 80% of the baby formula market in the United States is kind of dominated by these brands.
And I would imagine that if you are so huge, you're kind of calling the shots, right?
Like I would imagine at that point the FDA and other regulatory agencies have a good relationship with these companies already and trust that, you know, with some justification that they're doing everything more or less correctly.
Yeah.
So they probably have a lot of power just simply by virtue of being so big and connected.
That was also a lot of the reactions I would get.
When I would tell people I started an infant formula business, the reaction was often that, which is, oh, this industry is dominated by these two large pharmaceutical businesses.
And it was almost a series of questions to see if I was ready.
Did I understand what I was about to get into?
Because anyone who was up against really a monopoly or a duopoly in any industry is entering a fight to some extent.
And there was an ounce of naivety, probably, you know.
I knew it was heavily regulated.
And look, I credit a lot of the experience being at Airbnb.
I watched Airbnb go up against the hospitality industry.
The hotels, right.
The hotel lobbyists.
Yeah.
So I got a taste for what disruption was like.
And nothing fuels a mother more than knowing that what is blocking them from developing something better.
And giving their baby something better was an industry that was ripe for disruption.
All right.
So you're working on different recipes with these consultants.
And I mean, presumably, it's like, kind of break down what infant formula is.
It's powdered milk, right?
Presumably.
Powdered milk.
So it needs to mirror breast milk in its macro components, which is carbs, proteins, and fats.
Look, even going back then, this was.
It was me going to Wikipedia to learn this.
I'll never forget looking for a book, trying to figure out how to understand recipes and manufacturing and all of it.
And I found one.
It was a hardback book called The Biochemistry of Infant Formula Manufacturing Practices.
You can imagine how dry this book was.
And I found it on Amazon.
And I remember turning to my husband and saying, okay, honey, this book costs $217.
If I buy this book, there's no going back.
When we come back in just a moment, Laura gets an unexpected visit from the FDA, which sets her business back by a year and a half.
Stay with us.
I'm Guy Raz, and you're listening to How I Built This.
What I've learned from talking to hundreds of founders is that as a business grows, complexity can become a huge problem.
Suddenly, you've got different systems for finance, inventory, customers, operations, and they don't always talk to each other.
If I were building a company today, I'd want all of that in one place, with AI helping me make sense of it.
And that's exactly what NetSuite Next is designed to do.
You probably know NetSuite, the AI-powered business management suite that brings your financials, inventory,
commerce, HR, and CRM into a single source of truth.
NetSuite Next is the next huge leap in how business gets done, because AI is built into everything you do.
AI agents work alongside you to solve problems and handle routine work.
And anytime you have a question about anything, ask, just like you're having a conversation with a colleague.
For the first time ever, you can try NetSuite Next for free.
If your revenues are at least in the seven figures, go to NetSuite.ai.
Built for every industry, ready for every boardroom, NetSuite.ai.
Our presenting sponsor today is Anthropic, the team behind Claude.
Every founder on this show started with a hard question, not the marketing plan, the 2 a.m. kind.
Is this idea any good?
Am I the one to build it?
Should I quit my job?
Anthropic got built the same way, a public benefit corporation founded on
one hard question.
How do we make sure AI goes well for people?
So they asked over 100,000 people their hopes and their fears and are publishing what they find,
even the uncomfortable parts.
Me?
I've got my own hard question about AI.
Here it is.
If everyone has access to something that can help them write the business plan,
build the prototype, analyze the market, maybe even come up with the idea,
what separates the people who
actually build something from everyone else?
I don't have a clean answer yet, so I've been sitting with it with Claude.
There's hope in hard questions.
Ask yours at claude.ai.hibt.
If you travel often, you'll want to hear about this unprecedented offer.
For the first time ever, new Delta SkyMiles Reserve American Express card members
can earn two Delta Comfort round-trip flights for travel within the 48 hours of their trip.
Plus, you can earn 50,000 bonus miles towards your next getaway.
And who doesn't appreciate an elevated airport experience?
Delta SkyMiles Reserve card members get access to the Delta Sky Club,
your pre-flight oasis to recharge, with 15 visits and four one-time guest passes
each medallion year when flying Delta together.
That's up to $950.
Annual value.
Value estimate based on $50 per visit rate to purchase additional visits
or bring a guest to the Delta Sky Club.
Make every trip feel more rewarding with the card that upgrades your travel.
Apply today at delta.com slash card social.
Offer ends November 4, 2026.
Minimum spending requirements and terms apply.
Flights are fulfilled as flight certificates valid for Delta Comfort or Delta Main
to select domestic destinations.
Book 21 plus days in advance.
Up to $80 per person in taxes and fees apply.
Other restrictions apply.
Hey, welcome back to How I Built This.
I'm Guy Raz.
So it's 2018 and Laura's committed herself to creating a European-style infant formula
for the U.S. market.
But unlike most food startups, you can't just mix up formula powder in your home kitchen
and test it on people.
You know.
Yeah, how do you do that?
You get on a panel of babies.
So there's these essentially kitchens, micro kitchens that you can work with.
And they're innovation centers.
And a lot of big companies would turn to them and say,
I have this idea.
I want to go formulate it.
But they don't have a pilot plant or a pilot kitchen to go do it in.
And this is where the money went, right?
So as soon as we got to a place of having this formulation in hand,
it was a spreadsheet.
It was a spreadsheet of numbers.
And a list of ingredients.
I would then drive down to the innovation center,
which was about an hour outside of San Francisco.
And I would meet with the team there,
who were just a big, beautiful team of nutrition scientists.
They would go order the ingredients.
And we would work in a lab, essentially,
to formulate the product so that we could do some taste testing and sensory analysis.
But one thing to note, unlike other CPG products,
infant formula has to be made under a commercial,
socially ready manufacturing facility.
Part of the expense of this process is it's like almost like drug testing, right?
That's what makes a drug so expensive because the testing is so regulated and expensive.
Because if you break it down, it's like we're talking about like nonfat milk
and whey protein and coconut oil and safflower oil and lactose, right?
It's not, but it's the fact that it has to be done in a highly regulated
and highly controlled environment.
That makes it so expensive.
It makes it expensive to even like experiment with.
And that's where thousands of dollars went.
But yeah, you hear the stories of CPG companies who go down to the farmer's market
and they go sell their first product and they get some feedback and reactions.
We couldn't do that.
Okay, so when did you know that you had something good enough
that would let you kind of show it to people, you know, when you were ready to raise money?
So as soon as we got to a sample, which was a sample that you could
pour into a drink and you could taste it and you could also do a side-by-side,
you could make up Similac and Infamil and, you know, I remember sitting in the room
and you're looking at all of the different samples and once the color and the sensory
and now the nutrient testing of that product was coming back
and meeting all of the regulations that we knew we needed to hit, we were ready.
And that took several months.
I mean, presumably you were also able to, I mean, and it's safe, right?
You were able to test it.
You were able to test it on your own kids.
Oh, I was able to test it on my own kids.
And they all got different versions.
Right. Okay. So let's get – so you – 2018 is when you really start this process.
That's right.
And by the way, you register this name Bobby and tell us the story behind the name.
At the time, I thought I was going to call it Reform because I wanted to reform the industry.
But then someone said like, you know, cute baby names are always good or just using a human name.
And I was like, you know what? My daughter calls her bottle a Bobby.
She'd ask for it at night. She wants her Bobby.
I didn't even think twice.
I sent an email to my lawyers and I said I want to register the company named Bobby.
It can be Bobby with an I, Bobby with a Y, or an IE.
They ultimately responded and said IE is open. It feels safe.
I was like, beautiful. It even has a bit of an Irishness to it.
And that's the story of how we landed on Bobby with an IE.
Okay. So you have the name and you've got a prototype.
Yeah.
And you have –
I mean, at this point, you have some deep experience.
You've been at Google. You've been at Airbnb.
So you have developed connections, contacts.
And how much were you trying to raise initially?
Because this is going to take a lot of money with this approval regulatory process.
So what did you think you needed initially?
I got to a place at around eight months pregnant and realized taking the next phase meant raising institutional capital.
And my husband was all for it.
This is the time we've burned through every dollar that we've had here.
And I remember going, I will give myself until this baby comes.
And if I don't raise money then, I may put my pen down and have to revisit this at a later point.
You're still in the I hope this works moment.
So I thought I needed to go out and raise a million.
And that million sort of divided up in use of funds was really to just create the first batch of product.
And I hit up every Silicon Valley investor I knew.
I spoke to 64 investors.
Every day I was on the phone making introductions, driving all across San Francisco with my baby bump and pitching Bobby.
And, you know, the other things that happened during this period, I hired a designer to develop the first look and feel and the logo.
We designed the packaging.
It was the hustle towards a pitch.
But ultimately, after six months.
After 64 pitches, most of them said no and four of them said yes.
That's pretty good.
I mean, it's not a bad, right?
You got to take a lot of shots.
But I wonder whether, you know, because 2018, this is like the D to C boom is really in full throttle.
And this was a category that hadn't really seen any, you know, modernization.
So I would imagine that there was even those who may have said no, some excitement.
Or am I wrong?
There was a lot of skepticism.
A lot.
That journey of raising that first round was the biggest education to how I would go on to build a brand.
I remember one investor just couldn't shake the idea that there was anything wrong with corn syrup.
Corn syrup was in the bigger formula brands.
Correct.
I'm in the middle of the pitch and he says, well, what's wrong with corn syrup?
I met with another investor who said what I was doing was terrible.
That women should be breastfeeding.
They really say that to you?
Because that, I mean, that's surprising to me that somebody would be, even if they thought that in their brains, that they would say that to you.
I know.
I really wish I could say that that wasn't the case.
I said this earlier, but everyone has their own story.
And what he shared back with me when he said that was that his wife had breastfed all of their kids exclusively.
And he only knew.
He knew the world by which breastfeeding worked and couldn't understand why I would dedicate my time, energy and capital to going to making something that the world didn't need.
It was such fuel because it made me realize that the silent majority that were experiencing the shame and the guilt and also having to turn to something they weren't proud of, they weren't talking out.
And there wasn't a brand that was.
And there wasn't a brand that was speaking for them and making them feel like they belonged to something.
You feed your baby, if you think about this, you feed your baby a bottle or you breastfeed them seven times a day for their first year of life.
And yet parents were hiding their can of formula when a guest came over or they were lying to their pediatrician.
Yeah.
You know, the reason why I'm pushing back a little bit isn't because I doubt the veracity of the story.
It's more that.
You know, in years past on this show, we've had stories of founders who, you know, went out and tried to invest in part of the story was was the resistance they faced and maybe some insulting things they heard.
And in more recent years, I've kind of reflected on this and I've come to maybe a bit of an unusual conclusion, which is I actually have in some ways more respect for a VC who's going to be honest about how they feel and give their honest feedback.
And push back and then reject it rather than somebody who's like, great, love it.
And then you just get a note saying, hey, we're going to focus somewhere else somewhere, you know.
And I say that because if a person is giving feedback and explaining why they don't want to do it and are pushing back in ways that might even be a little bit offensive, it is still a data point.
I would not be who I am and the company would not be where it is today without that feedback.
Yeah.
And, you know, remember at the time, I'm also eight.
And most people thought I was building something as a passion project for my own baby.
I found I was dismissed as the potential entrepreneur and pitching the market size and what this business could be because there was a lot of personal storytelling tied up in this.
You know, I wasn't.
Think about the pitches that were coming in.
These pitches were scalable and sexy.
I'm walking.
I'm walking in talking about powdered milk that is owned by the pharmaceutical industry that is is controversial.
But the yeses I got were game changing.
It was the first sign of belief.
And I am so grateful because it was only two weeks before having my second baby did I get funded.
And there was such a deep breath.
You raised the money.
I ended up raising two and a half million.
So you've got some validation.
And.
Then you have your baby.
And tell me about tell me about your life at that point.
Bobby was now, you know, it was like a living, breathing.
Your third child.
It was my third child.
And I took a few days off with my second baby.
But it was a very different emotion than I had with the first.
I wanted to get back to building the company.
I wanted to get back to it so badly that my son, Colin.
Sort of came along that journey with me.
He was side by side.
This is your second kid.
My second kid.
Yeah.
He's under the desk working with me.
And your husband, he's working too, right?
He will.
I'm presumably you guys are he's helping, but he's also doing something.
Yeah, he's he's helping.
He was a founder and CEO of his own design firm, and he was heads down, you know, making I wasn't yet really earning much money.
Our first round of funding, I gave myself my first salary.
Which was, I think I paid myself less than $50,000 and, you know, we're living in San Francisco with two kids.
So my husband was very, very supportive and also really helped bridge our needs at that time.
Okay.
So now you've got two and a half million dollars.
It's 2019.
Tell me what the first few steps are now.
What are you like in terms of let's let's talk about hires first, because up until this point, it's you and and just contractors, right?
Contractors.
I had two.
I had two full time scientists at this point.
On staff.
That's right.
And something that really I knew deep down was that I wanted to build a culture and build a team.
The constant question on my mind was, do I do that with a co-founder?
And at the time, I had so many investors say to me, you know, your co-founder needs to be a scientist.
They need to they need to be the opposite of what you are.
Sounds logical.
Sounds very logical.
Yeah.
Tech business, they would say, go get your CTO.
And I spent a long time thinking through that, but I didn't come from that world, which means I didn't have a long term relationship with someone that would have played that opposite.
What I did have was someone, Sarah Hardy, who I had worked hand in hand through thick and thin through building Airbnb.
You're going through a lot of highs and lows.
And she was at Airbnb at the time.
Correct.
She was at Airbnb at the time.
And I'm telling her all about what I'm doing.
And remember, we have worked together while having babies.
And we never talked.
We never talked about our problems, breastfeeding or going through motherhood.
And this was the first time that we were sharing in that experience.
And she worked within the HR and people organization.
And not only was she totally understood on the mission, but she was also bought in on building a next generation workplace and culture.
And it's interesting because it's such an unconventional, I guess I'm kind of giving away the story because you would ask her to become your co-founder.
but it's an unconventional, like everyone's saying go find
scientist, a CTO, and you would think culture will come later. You know, we can deal with that later.
Culture never comes later. It was really important that we built a culture that could
last longer than our product, that could sustain the hits of the business. Because there was going
to be, there was going to be hard times, but a really good culture can get through those.
Okay. So she comes aboard.
She comes aboard. And then it was a series of unconventional hires.
The next hire I made was an Emmy Award news anchor. And the Emmy Award news anchor is now
my chief brand officer. And I would say when you look across all of our key hires,
every single one of them, their resume does not match what they have built or done at Bobby.
Were they all women?
You know, they were. Now, we do have diversity. We do have men on the team.
But most of the unconventional hires were women. That is true.
And early hires, I guess.
Yeah. All of the early hires were women.
I mean, it makes sense because you can relate based on obvious experiences. So,
okay. So you start to build a team, more of an executive team, and you've got this prototype.
But now, first of all, where are you, where were you able to make it? Because you don't,
you know, I mean, if you want to make a food brand, there are lots of places in the U.S.
where you can do that. They are regulated, but not like a, I mean, this is like making a drug,
right? And I can't imagine probably the
existing big brands have their own vertically integrated systems. I know there's one
big company called Perigo. They make brands for a lot of different baby formulas, but
you're probably really small at that point. So where, where could you make your formula?
So Perigo was the only, it is the only manufacturer of infant formula here in the U.S.
outside of the vertically integrated.
Yeah. Wow. Outside the big ones. It's the only one that, because they don't have their own label.
They make, I think they make,
they make Walmarts and all of them, Costco and Earth's best at the time. Yep. So I remember
calling this contract manufacturer and they declined, you know, we're, we're moms in a
basement. They're not going to take us on. This wasn't something that they typically do.
Okay. So what did you do?
So I went to the birthland, the homeland of infant formula, which is in Germany.
And I came across a family run manufacturer led by a woman,
led by a mom. We spent many a week going back and forth about the potential of her being able to
make our product. And she ultimately said yes. But there was one major dilemma, which was
manufacturing a product like infant formula in Europe meant that it didn't match the regulations
of making infant formula here in the U.S.
Yeah. And by the way, they couldn't match them. It was not possible.
It's a manufacturing process.
Okay.
So you would have to change the way you were manufacturing. Again,
is it because anything was wrong? No, they were just different. But that didn't stop me. This
was the only place I was able to get my product made and made Bobby, brought it over as a pilot
and decided to make what I thought was a very smart decision to position it as a supplement,
as a companion formula to breast milk, which means that it moved out of the category as being the
sole nutrition. And now it was in the supplement category.
Companion formula. So just something else to give your baby.
Something else. Exactly.
Okay. And the idea was you were going to set up, you say, a pilot program. This was going to be
a direct to consumer.
Direct to consumer. We only started selling it to San Francisco families,
and we would personally go and deliver it. I remember various, we had 93 customers.
And you delivered them canisters.
Canisters. Yeah. Canisters of the formula.
And it was branded and everything. It said Bobby on it.
Branded and everything.
Okay. Companion formula.
Correct.
And again, because if it said infant formula, that triggers a different set of rules.
That's exactly right. Now, coming from a world of tech and disruption,
I thought this was a genius way to enter.
Yeah. You just go for it.
You know, good start. We got a product into market.
We'll see how this goes for a while. And then we'll move into the process of maybe going back
to that contract manufacturer and seeing if they'll make our product then.
But we were not on the market for less than two weeks before I got a phone call
from our warehouse manager who said the FDA is at the warehouse.
An FDA inspector knocks on the door and comes on in showing their badge?
Correct. By which anyone who comes from
the food and drug space, the FDA doesn't just normally show up. That just never happens.
But the FDA shows up, and I go down to the warehouse, I meet the FDA officials,
and they look at the product and they say, "Hey, we hear that you're selling infant formula."
And they pick up the can, they look at the ingredients, they look at the formula,
and they said, "Yeah, I see what you're doing. I can see that it's positioned as companion formula.
However, it looks like a duck. It quacks like a duck. This is infant formula."
By the way, how do they even know about it? I mean, how do they even get
tipped off about this?
You know, here I am, almost eight years later, and I'm still wondering the exact same thing.
We had gotten some media attention on TechCrunch, and our launch of bringing this formula to market
created some stir, and our belief is it probably made its way to the FDA, and FDA's thought,
"This looks like another way to bring formula to market, and this doesn't match the regulations."
I mean, you know, I don't know if this is true, but I don't know if this is the right thing to do.
I don't know if this is the right thing to do.
But we were so small, and the very fiery group that we were serving at the time, I remember them coming, and we had this rallying cry from them, being like, this is crazy.
We got to figure out how we get the FDA to get this approved.
We ended up firing up a community to support our next moves.
But you were angry.
You felt like this was unfair, and you were angry.
I mean, on the one hand, I'm very sympathetic.
I'm very sympathetic to this idea, because it's like, let's just get it out there and try it.
And it's very much a Silicon Valley entrepreneurial in that spirit.
At the same time, I'm like, yeah, but it's like, you can't.
This is like one of those things.
You can imagine if there wasn't this regulatory environment, it could be abused, and you could have really dangerous products going into babies.
100%.
And we were used as an example.
And to be fair, if they didn't use us as an example.
If they didn't use us as an example.
It invites more, as you said, more ways to be able to enter the market that could potentially be dangerous.
But you got bad press probably right away.
We got some bad press, but we were so small.
We barely existed.
But what did come from it was that I sat there for, it was a few weeks.
We debated what the next moves were.
There was no manufacturer to turn to.
And one day I opened my email, and there was an email from the one contract manufacturer that makes infant formula.
Parago.
Parago.
And said, we watched what happened with the recall, and we want to make your product.
They said that we, because you had approached them before, and they were not interested in working with you because you were too small, presumably.
Correct.
And now that they saw this kind of fiasco, they called you and said, why would they call you and say they want to work with you?
They pointed a lot to how we handled it.
Yeah, how did you handle it?
What was your public response?
Well, as I put out a letter of apology.
It wasn't about being defiant.
It was about being compliant.
Very different to maybe what it was like being in the tech industry.
And that letter resonated, and we got this email.
And it was actually an internal champion.
He led their R&D team, and he was watching all of this.
But what he was so impressed with was the product that we had developed was the one that he was enjoying.
That he was internally championing for years.
That he wanted to develop a new kind of baby formula.
He wanted grass-fed milk.
He wanted to lean into European nutritional standards.
He was a huge fan of DHA.
So you can imagine being in a big company, and you are a voice in there trying to champion change.
And he's watching that change happening outside with us.
But I give so much credit to those internal.
Like Pedro is his name, was really the internal voice.
To tap his manager on the shoulder and say, we should give them a call.
Right.
And we spent the next 18 months course-correcting our supply chain to get our product made.
Okay, because the actual recipe was going to remain largely the same.
It was just the production process that violated, that meant that it could not be labeled as infant formula or described that way.
But I still have to, I mean, because that was a significant setback.
Because all of a sudden, you're not going to be able to. test this with customers, real customers, and
you're going to have no revenue coming in and right in theory you should have done that from
the beginning but at the same time it's so onerous and slow and can really in the meantime there
could be competitors coming in who are better funded or more connected and and so was any part
of you like freaking out when this happened oh of course you go through your own identity crisis
I had investors say, you got to change your name. Bobby could never exist.
Because it was black. The name was blackened now.
And I would have other people say, this is going to be like your C-section scar. You're going to go, it'll always be there.
And then on the other side, there was a lot of folks who came forward and said, like, you need to lean into the story.
This is a story of David versus the Goliath, and you need to get out to the FDA, and you need to own this moment.
I did ultimately decide to own it and stick with it.
And we ended up actually getting some press to speak to the full story.
You know, even part of that press makes you cringe, and you wonder, if we didn't make this move, what would we do?
But I also don't believe in playing hindsight.
And that email that came in from that contract manufacturer to say we'd make your product,
I don't know if that ever happened.
I think you also attracted another investor because of that.
We did.
What would have been a fiasco, but it was kind of turned around.
And I guess there was an investor who also liked how you handled this.
It piqued the attention of those that wanted to see this industry change and probably recognized, oh, this isn't easy.
And if Laura does get through this, this could be very big.
So we had an investor come forward that we had spoken to in the past as well.
And they ended up saying, oh, this isn't easy.
And they ended up funding the business another $4 million, which allowed us to spend the next 18 months, get our product off the line at this facility and into the FDA.
Okay.
Here's my question.
You had a formula.
You had an ingredient list.
And from my understanding, the problem with how it was made in Germany wasn't the ingredients but how it was made, like the order of operations or whatever.
It's not an FDA-approved factory.
Now you're going to get it made by Perigo, which is, you know, they make all this.
Why was it going to take so long?
I mean, you had it all ready to go.
Because we were obsessed with certain suppliers we wanted to use that they weren't yet using.
So it wasn't actually the FDA.
It was suppliers.
It was both.
It was both.
So shifting your operation from one place to another means sort of shifting the entire supply chain to be able to get made there.
And if there was a supplier that they weren't yet using,
that means they would have to run a product trial of that off their own line.
So there's a long process.
It's not as simple as just switching it and getting it made.
And that process took some time.
And then once they were ready, you then have to submit it to the FDA.
And submitting it to the FDA, we waited another six months before we were able to get the green light.
Because you're in a queue, right, of people.
You're in a queue.
They got to go through a bunch of applications.
That's right.
So what is your team doing at this point?
I mean, you're waiting.
You've got a formulation.
You're waiting.
And then you've got six months of waiting for FDA approval.
What, in the meantime, is your staff, your team doing?
So we're still a relatively small team.
But one of the things that we started doing was sort of gearing up the brand for when we would come to market.
And one of those was to meet with community members, meet with parents every week.
And there was this belief.
I had someone share with me once.
And I said, you know what?
Every week that we would find on Instagram and different socials and Twitter who were talking about the feeding journey, and we would invite them into conversations.
They were the founding community that helped accelerate the business when we ultimately launched.
And they still do.
I see them chiming in on Instagram all the time.
And during this period, by the way, I also went on to have my third baby.
So the idea comes to you in 2017, roughly, 2016, 2017.
And it's good.
It's going to take over three years before you get an FDA-approved product ready to go.
But meantime, it's COVID.
COVID's gone, right?
So are you guys working in an office?
Are you working remotely?
Like, how are you, even before COVID happened, how were you, did you rent space?
You had a warehouse, I know.
We're in my basement.
Right.
In my basement in San Francisco.
It's a big team of moms.
And COVID hits.
So everyone goes home and they start working from home.
But it was August of 2020.
We were on a Zoom call, and my head of regulatory sends me a Slack.
And she said, Laura, the IFN, which is essentially the letter from the FDA, just came through.
And she said, we got the green light.
Wow.
Now, when most businesses were in a place during COVID of going, will we exist?
Do we have the capital to do so?
Does the world even need us?
In this moment, the most reassuring thing during this time was that we were making a product that no matter a recession or another pandemic, this product was needed.
And not only needed, people were looking at the quality and safety of what they were consuming in a completely different way.
But you had no money coming in.
So did you have to raise more money to, because you got to order product, you got to launch direct-to-consumer, and you got to start a marketing campaign.
Correct.
I mean, look, that second round of capital that came in, that $4 million, really did help.
So the intention was not to go out and raise just yet.
It was to get to market.
We're all sitting on the edge of our seat wondering, how are people going to react?
And the amount of times investors would say, what's your forecast for the year?
What do you think you're going to do?
I'm like, I have no clue.
Come on.
It's putting a finger in the air.
And anyone who says before they launch that they're setting a forecast they believe is accurate is totally lying.
And you're going out on a hope and a whim that there will be good reception to this and it will take off.
When we come back in just a moment, Bobby finally launches and Laura suddenly has to take manufacturing into her own hands.
Stay with us.
I'm Guy Raz and you're listening to How I Built This.
When you run a small business, you have to wear a lot of hats.
You're the hiring manager, the payroll department, and the benefits team all wrapped into one.
And after talking to hundreds of founders and running a business myself, I know how overwhelming wearing all these hats can be.
Thankfully, Gusto is here to take a few of those necessary tasks off your plate so you can get back to the bigger picture.
Gusto is online payroll and benefits software.
Built for small businesses.
It's all-in-one, remote-friendly, and incredibly easy to use.
So you can pay, hire, onboard, and support your team from anywhere.
Save time with built-in automated tools like offer letters, onboarding docs, direct deposit, and more.
Plus, get direct access to certified HR experts to help support you through any tough HR situation.
Try Gusto today at gusto.com slash built.
And get three months free when you run your first payroll.
That's three months of free payroll at gusto.com slash built.
One more time, gusto.com slash built.
I'm Guy Raz.
So it's January 2021, and after years of setbacks, Bobby Infant Formula is finally ready to launch.
But Laura has to be very careful about how they promote it.
What was your message?
Because I imagine the messaging is also highly regulated.
Like there's things you can and cannot say or things that you have to be careful of by risking like class action lawsuits.
Oh, 100%.
One of the earlier hires during that founding team build was my head of regulatory.
And she came from having worked at the FDA.
She had worked at. At Abbott.
She schooled us on what we can or can't say.
And today, she will still turn to me years later and be like, Laura, you cannot say that.
The marketing team needs to remove this.
But it must have made the marketing team crazy to have somebody. Oh, it still does.
Like, can't say that.
Can't say that.
Like, what's something that you couldn't say?
So the biggest thing to avoid was making any functional benefit claims.
Like smarter babies are better for your brain health.
Exactly.
You could say maybe brain health, you could say.
You're kidding.
Get us a chance to go to Harvard.
You know, like tying the nutritional value of this to very specific outcomes was a big no.
And as a brand, we weren't here to try to. try and shame different formulas or point to specifics.
At the end of the day, we were a European-style formula
that was made here in America.
And that positioning of our product, it resonated.
That's all you had to say, European-style recipe.
That's all we had to say.
And then where we put a lot of the positioning and the brand work
was around the emotional claims, not the functional ones.
And the emotional ones were really about
what is the help and support and the recognition
that parents are going through in this moment.
It was telling the stories of those
that weren't able to exclusively breastfeed.
So there was the product piece of it,
but then there was also the cultural society
and stigma pieces of it that really resonated
when we came to market.
So you launched this in January 2021,
and it's still COVID.
I mean, people are still working from home,
but this is direct to consumers.
I mean, you hit the go button, and what happens?
Oh, it took off.
We realized we had immediate sort of product market fit,
brand market fit.
But what we failed to do was that we didn't have
really business model fit or maybe forecasting fit.
We ran out of product very quickly.
I remember the moment being told, you know,
you're either great marketers or terrible forecasters
or maybe both.
And the lead times to produce more infant formula,
again, because of it being so complicated and regulated
and also capitally intense,
we stocked up just enough,
but we weren't ready for the amount of demand
that came through.
What was the lead time?
Lead time is five to six months.
Five to six months from the time you order it
until the time it's delivered?
Correct.
And this is not being put on a ship from China
in a container.
No.
This is made. Wow.
When you make product for infant formula,
you actually have to let it sit for a period of time.
And you have to have the testing go out
and you've got to wait till those testing results come back
and you're in the full clear
before you can bring product to market.
So the forecasting, and when you're a new company,
you want to be careful that you don't order too much
and then find all of your capital wrapped up in inventory.
But also when it comes to feeding babies,
you also don't want to have gaps
in serving those that you buy.
So we ended up running out of inventory,
but not on our existing customers.
We were able to, because we were a subscription business,
manage who got that product and who didn't.
So we actually turned off our growth and our top of funnel.
And that was a very intentional decision.
I think in that first year, which is just remarkable,
you did $16 million in sales.
That's right.
We'd hoped we would do around $4 million.
And we ended up doing $16 million.
Wow.
So that year, 2021,
you decide to move to Washington, D.C. from San Francisco.
Because I guess at this point, it's because of COVID era,
you guys are totally remote anyway.
Tell me the decision to uproot the whole family
and move to Washington, D.C.
I mean, it was a few things.
It was definitely post-COVID, three kids.
And then there was an element of this,
which was both me and my husband,
directly or indirectly,
were working with government agencies.
Oh, because your products were regulated by the government.
Exactly.
And he's an AI, I think, right?
He's an AI.
Okay.
And he was doing some work with the government as well,
also supporting on some design work during COVID.
And the advantage is you are close to the FDA.
Correct.
You're close to HHS.
So it was also strategically important for you to be there.
It was.
Okay.
I imagine, I think it's the case,
that one of the reasons why the two big,
you know, 800-pound gorillas in this space
are Similac and Enfamil are, you know,
they're widely used for a reason,
but they're also a huge amount of their revenue
comes from government programs,
WIC, Women, Infants, Children, I would imagine, right?
That's right.
Basically, the formula is eligible
for these government programs
that help people who can't afford these products.
That is huge if you have that contract.
Right?
If you have the ability to get your product approved for WIC.
So WIC, these behemoths, these Goliaths,
saw an opportunity to be able to subsidize
the cost of this for the government.
Every few years, you go and you bid for a contract
and then a brand will win that state.
What that means is, as a mother,
you're going in and if you're buying your formula on WIC,
you can only choose that brand.
Wow.
Exactly.
And the fact that 50% of babies born in this country
are choosing a formula under WIC,
which means they are limited by choice,
huge opportunity to reform this program.
But it starts with more businesses and brands existing.
And it takes companies like Bobby to gain more market share
because the reality is, even though I want to see a change,
I'm not yet big enough to be able to serve WIC
individually.
Okay, so this is still an ongoing thing, right?
Because you're, I think, I looked into it.
I think Enfamil and Similac are primarily what's available
across the country for WIC.
In the meantime, you've got this first year,
a great first year, right?
And then comes 2022.
And there's this like crazy infant formula shortage,
which some people might remember.
I mean, the shelves were like empty.
People could not get baby formula.
And I think part of the reason was,
is that Abbott, which makes Similac,
had this huge recall, right?
Correct.
So the recall happened because Abbott had a contamination
in one of their facilities.
And that contamination led to very sick babies,
some fatalities.
It was very serious.
They had to shut down that facility.
But at the time, I turned to the team and I was like,
this is going to have a very negative consequence
on the industry.
Because a market, we've gotten to a place now
where they're not just serving a large percentage of it.
We've become reliant on them to feed babies.
There wasn't more manufacturers like we've already talked about
that could just turn on the faucet really quick
and just all of a sudden start producing more.
You could not do that.
You couldn't get, I mean,
Parago couldn't just do that for you.
You couldn't just flip it on.
Now we immediately started ramping up
and we started producing more product
than we had even dreamed of in 2022.
Right.
But at the same time,
it's like how many rooms are in a hotel?
Like when the inn is full, the inn is full.
So I imagine that parents who are looking for alternatives
all of a sudden start flooding your website.
They do.
And you can't serve all those people, presumably.
Yes, exactly.
And at the time, we're fully stocked up.
We've learned from our first year.
So now we're sitting on a lot of inventory.
But what ended up happening was that recall happened
and our goal was to build a new website.
And our growth skyrocketed.
It was numbers that we had never seen before.
But the problem is that we're growing faster
than our ability to replenish product.
And if we keep growing,
we run the risk of using inventory that we have
that should be given to our existing subscribers.
We're going to end up acquiring too many people
and we won't be able to serve them.
Now, this was like a COVID situation.
You're going, yeah, yeah, yeah.
But it's all going to be over in a minute.
Like there's no chance this could happen.
It could go on forever.
And, you know, you can't forecast
how long this stuff's going to go on.
So I did a round of phone calls.
I called my board.
I'm going, look, here's a little bit of the dilemma.
Most of them were like, this is crazy.
Just keep the growth going.
Like these moments don't come around often.
Like great moment for the brand.
But I went to bed that night
and I remember taking off my CEO hat
and playing the mother and going,
if I signed up to feed my baby Bobby
and then one day received an email to say,
sorry, we don't have product.
To send you this month.
You've lost me.
You've lost my loyalty.
I can no longer stand behind the company.
And the next day we decided to turn off the website.
Existing customers could order,
but new customers could not.
That's right.
It made people realize what we were prioritizing,
which was our existing subscribers.
And that loyalty has paid off years later.
That year, year two, full year,
84 million in sales.
Just growing like crazy.
But you have a dilemma and an opportunity,
which is, you know, you know, there's demand.
And you also know that you are constrained
because you have, you're depending on one manufacturer
who a lot of other people are depending on
and their capacity is probably at full throttle.
So you have to presumably start to think about
how to solve this,
how to become more vertically integrated.
Correct.
And the idea of owning,
manufacturing, you know,
even 18 months into starting a business
was not something that was on the agenda.
That was not a roadmap item in any way.
But I changed my mind very quickly.
And when I realized that I was one phone call away
from potentially being out of a business
and not being able to serve this beautiful demand,
I had to own my own destiny.
And I was introduced to really a founding father of formula.
He had built a company 22 years before that
selling toddler formula.
And he made a much wider,
wiser decision than any of us to go break
ground and build a modern infant formula facility in the heartland of this country in 2019.
And this was for the brand Nature's One, right?
So this was a small brand that decided to build their own facility.
And I imagine it's not cheap to build something like that.
He raised capital, but this was happening behind the scenes.
There was a building of a facility that was still underway.
And by the time we had come to the conclusion that we needed to own manufacturing, they were now completed.
When we came forward with huge demand and he had the perfect facility and also the need now for capital to be able to invest in this,
we decided to purchase this facility and combine our businesses.
And also the brand?
Correct.
So you acquire Nature's One. And does Nature's One still exist as a standalone brand?
There is still. The baby's only toddler formula. That's right.
Got it. Okay. So you buy this facility in Ohio.
But from what I understand, because it's 2023, you're not actually producing right away.
There's still things you have to do there.
Yeah. And this is the most painful part of it all, which is I've now acquired an expensive fixed asset, but we had yet to get full FDA approval.
Uh-huh. You had to get. Right. Okay.
You had to re-approve the facility. You had to re-approve your formulation.
Right.
And nothing happened overnight. I still relied on my contract manufacturer to serve essentially our demand for the next two years.
And we went out of stock again in 24 for almost seven months.
Wow. I mentioned earlier about the two, you know, Abbott that makes Similac, and I mentioned Mead Johnson that does Enfamilac.
I should have said that Mead Johnson was acquired by Reckitt, another company. So I guess technically they. That's right.
I don't ever see it. And I mention this because I know that it's just a weird moment in history where everything is a minefield, right?
You have dealt with some of this. You were invited to the HHS in 2025 by the Secretary of Health, Robert F. Kennedy.
Lots of people love him. Lots of people don't love him. It's just the world we live in, right?
And you were invited along with the heads of these other big baby formula.
Correct.
Like Reckitt and Abbott and Perigo to come meet with him. And you got some grief and pushback from your customers who are like, they think that the brand should represent, you know, certain political perspectives.
So, yeah, tell me about just navigating that. I mean, you were invited to meet with him. He's the head of the Health and Human Services Department.
You are in this space. It kind of is a no-brainer to me, but give me a crap for that.
As an infant formula, you're regulated. So, you know, to put it another way, it's like the head of HHS is like my principal.
And when the principal in your school calls you to the office, you go to the office.
And it happens to be a person who has raised some eyebrows.
Now, what is not being spoken about is that for the multiple administrations that have been in seat, I am not choosing when and if I walk into that room or whether I take that.
Previous administration, this administration, if I have an opportunity to shape the face of our industry and to be the voice of parents and be the voice of mothers, you better believe I'm going to take that call.
And we can't look at what we do as politicized.
There's nothing more bipartisan than what it means to feed babies.
And if we are building a legacy business and we're doing this right, it will mean that we're going to be dealing with characters that are polarizing.
It will mean we're going to be dealing with different people.
It will mean we're going to be dealing with different administrations along the way.
And our job is to remain as centrist as possible through this position.
So, I think it makes a lot of sense.
Here we are in 2026 now, we're talking, and you guys are growing and growing in hundreds of millions of dollars in sales now.
That's right.
And you have, I read, about 4% market share in the U.S. now, which is pretty great.
Just under 4%.
Just under 4%.
And tell me about the ambitions here.
You know, in 10 years' time, what do you want Bobby to look like to be?
I'll start first just with the culture change.
No one should be embarrassed about how they're feeding their baby.
When I look back in 10 years, I want to be at a dinner table conversation and to be able to hear a new mother talk about the formula she's using.
In fact, I want to see her wear a sweater.
Wear a sweater with a brand across her chest because this is something that is playing such a big role in her life that she has that emotional connection to it.
Secondly, I hope we change policies because they're broken.
Mothers are overlooked.
Parents today are up against too much society pressures.
And then lastly, I think growth will follow.
And hopefully one day we're not as big as the similacs and infamiles of the world because I don't think anyone should be.
But ideally, we're serving a good 10% of the market.
When you look at the journey you took, you know, and how quickly, I mean, really, this started.
They start selling in 2021.
Here we are five years later and you're in hundreds of millions of dollars and a respected brand.
How much of that do you attribute to the work and the grind?
And then how much do you think just had to do with, like, luck and circumstance and what was going on in the world?
I mean, as an Irish woman, I have very strong belief in luck.
I don't believe there's a shortage of luck.
I believe that there's a shortage of awareness to how you use that luck.
Not be where we were if we did not hustle with harsh and a lot of hard work to get us here.
So luck is the invitation, but hard work is why you're sitting at the table.
It's a good mix.
It's a very good mix.
That's Laura Modi, co-founder of Bobby.
By the way, Laura says one of the things she's proudest of is the company's advocacy group, Bobby for Change, which is working to influence policy in the industry.
And one of the things the group has done is to help introduce a bill in Congress that would allow women who've had breast cancer to get insurance coverage for infant formula.
Hey, thanks so much for listening to the show this week.
Please make sure to click the follow button on your podcast app so you never miss a new episode.
And if you're interested in insights, ideas and lessons from some of the world's greatest entrepreneurs, please do sign up for my newsletter at GuyRoz.com or on Substack.
This episode was researched and produced by Alex Chung with music.
Composed by Ramteen Arablui.
It was edited by Neva Grant and our audio engineer was Robert Rodriguez.
Our production staff also includes J.C. Howard, Casey Herman, Chris Messini, Carrie Thompson, Carla Estevez, Sam Paulson, Catherine Seifer, John Isabella and Elaine Coates.
I'm Guy Roz and you've been listening to How I Built This.
We get support from Engine.
A lot of founders start with a product or an idea.
But at some point, the business becomes something else.
Think about Brian Scudamore.
He started 1-800-GOD-JUNK with one truck and a vision to make junk removal a real brand.
That worked.
And then it became hundreds of crews across. Multiple cities.
Trucks on the road every day.
Routes changing by the hour.
And a team that had to be in the right place before the customer even called.
Or Beryl Stafford, who started Bobo's by baking oat bars in her kitchen.
Next thing she knows, she's flying to retail meetings, demoing at trade shows, managing distributors coast to coast, running a national food brand out of what used to be a family recipe.
Or Tom Hale, who built backroads around the idea that active travel could be a premium.
That means guides in six countries, gear shipments, guest logistics, thousands of moving pieces that all have to land before a single trip begins.
Different businesses, same truth.
Here's what I've noticed after talking to hundreds of founders.
The hard part is rarely the big idea.
It's what happens when the idea works.
Suddenly, you've got people on the move and all the logistics that come with it.
That's the real test.
And that's why I think Engine is worth knowing.
Engine is the fastest-growing modern travel and spend platform in the country, built for small and medium-sized businesses.
The average business traveler spends 45 minutes booking a single trip on a legacy platform.
With Engine, that drops to as little as two and a half minutes.
Last year, Engine customers saved $318 million on travel.
Average savings of 26% on hotel bookings.
No contracts, no booking fees.
More than 1,000 businesses join Engine every month.
Join them and get $500 when your business signs up and starts traveling at engine.com slash built.
Podcast Summary
Key Points:
The founders of Bobby, a baby formula company, were driven by a deep personal need to improve infant nutrition, especially for mothers facing shame or difficulty with breastfeeding.
They identified a major gap in the U.S. market
The startup faced significant regulatory hurdles, including being stopped by the FDA when they initially launched as a "companion formula" that was misclassified, forcing a costly and lengthy reevaluation of manufacturing and labeling.
Despite early skepticism and resistance from investors, the founders persisted, building a team of women with shared experiences in motherhood and innovation, which strengthened their culture and credibility.
A pivotal moment came when a key contract manufacturer, Perago, reached out after seeing the FDA incident, expressing interest due to the company’s commitment to quality and patient-centered values.
The journey highlighted the importance of transparency, resilience, and community in navigating complex regulations and public scrutiny.
Bobby’s eventual FDA approval after 18 months of effort marked a turning point, validating the product and opening the door to a broader market.
The story reflects how personal pain can fuel disruptive innovation, especially in industries where traditional systems are rigid and unresponsive to real-world needs.
Summary:
S. infant formula market was stagnant, unregulated, and failing to meet modern nutritional standards. Inspired by European practices—such as higher DHA and balanced iron levels—she created a safer, more natural formula for babies.
Initially, the venture faced skepticism, regulatory challenges, and a major setback when the FDA intervened, accusing the product of misrepresentation. Despite this, Laura’s team remained resilient, building a community of parents and a deep understanding of maternal challenges. A key turning point was when a major manufacturer, Perago, expressed interest after observing how Bobby handled the crisis with transparency and integrity.
After 18 months of rigorous reform and supply chain retooling, Bobby secured FDA approval. The journey underscored the power of personal experience, empathy, and persistence in disrupting a deeply entrenched industry. The product was positioned as a companion to breast milk, not a replacement, allowing it to enter the market legally and ethically.
Ultimately, Bobby’s success was not just in product innovation, but in creating a compassionate, inclusive narrative that resonated with parents who felt shame or exclusion in traditional parenting advice. The story highlights how small, human-centered ventures can challenge established systems when driven by genuine need and unwavering conviction.
FAQs
It helps keep engines three times cleaner in port fuel-injected engines, which can lead to better performance and improved gas mileage.
Because small, unseen improvements can significantly enhance customer experience and product quality, even if customers don't notice them directly.
A SoFi personal loan can consolidate high-interest debt into one low-interest monthly payment with no fees, helping users create a clear path to debt reduction.
She noticed that U.S. baby formula had not changed in 40 years and that many parents felt shame or guilt about using formula, especially due to lack of choice and regulation.
The FDA intervened because the product was labeled as a companion formula but appeared similar to infant formula, which triggered regulatory scrutiny and required reworking of the supply chain.
By staying committed to its mission, transparently sharing the challenges, and demonstrating real-world need, especially from parents who felt judged for using formula.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.